Here, we have shown that USP21 over-expression promotes HCC cell growth, cell cycle progression and in vivo tumorigenesis (Fig. 2), while knockdown of USP21 inhibits these processes (Fig. 3). The gene discussed is USP21; the disease is hepatocellular carcinoma.